Article Details

Morgan Stanley Sticks to Its Buy Rating for Repare Therapeutics (RPTX)

Retrieved on: 2021-04-19 18:44:19

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Sticks to Its Buy Rating for Repare Therapeutics (RPTX). View article details on hiswai:

Excerpt

Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Repare Therapeutics (RPTX) today and set a price target of $45.00. The company's ...

Article found on: www.smarteranalyst.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up